Myelin oligodendrocyte glycoprotein (MOG) gene polymorphism is not associated with migraine diseases in the Turkish population

dc.contributor.authorEtem, Ebru Onalan
dc.contributor.authorBerilgen, Said
dc.contributor.authorOzel, Seda
dc.contributor.authorElyas, Halit
dc.contributor.authorMungen, Bulent
dc.date.accessioned2026-08-12T18:13:02Z
dc.date.issued2011
dc.departmentFırat Üniversitesi
dc.descriptionEuropean Biotechnology Congress -- SEP 28-OCT 01, 2011 -- Istanbul, TURKEY
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Biotechnol Themat Network Assoc
dc.identifier.doi10.1016/j.copbio.2011.05.337
dc.identifier.endpageS106
dc.identifier.issn0958-1669
dc.identifier.issn1879-0429
dc.identifier.startpageS106
dc.identifier.urihttps://doi.org/10.1016/j.copbio.2011.05.337
dc.identifier.urihttps://hdl.handle.net/11508/64161
dc.identifier.volume22
dc.identifier.wosWOS:000295310800330
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier Sci Ltd
dc.relation.ispartofCurrent Opinion in Biotechnology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleMyelin oligodendrocyte glycoprotein (MOG) gene polymorphism is not associated with migraine diseases in the Turkish population
dc.typeConference Object

Dosyalar